Contact
Please use this form to send email to PR contact of this press release:
Sarcomatrix Therapeutics, Corp. Acknowledges EDAWN's Support in Advancing Biotechnological Innovations
TO:
David Craig
Sarcomatrix, Inc.
+1 415-246-3311